News
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...
Analysts questioned whether the complete response letter Replimune received was evidence of changing approval standards at ...
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results